Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. In Regard to Kelly et al.

Bahl A, Kapoor R, Bhattacharya T, Sharma SC.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):237. doi: 10.1016/j.ijrobp.2013.09.044. No abstract available.

PMID:
24331672
2.

Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer.

Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e143-9. doi: 10.1016/j.ijrobp.2012.09.035. Epub 2012 Nov 29.

PMID:
23200173
3.

In reply to Bahl et al.

Kelly P, Crane CH.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):237. doi: 10.1016/j.ijrobp.2013.09.042. No abstract available.

PMID:
24331673
4.

Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.

Coia L, Hoffman J, Scher R, Weese J, Solin L, Weiner L, Eisenberg B, Paul A, Hanks G.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):161-7.

PMID:
8083109
5.

A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.

Murphy JD, Christman-Skieller C, Kim J, Dieterich S, Chang DT, Koong AC.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1420-6. doi: 10.1016/j.ijrobp.2009.09.075. Epub 2010 Apr 14.

PMID:
20399033
6.

Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma.

Huang J, Robertson JM, Ye H, Margolis J, Nadeau L, Yan D.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1120-5. doi: 10.1016/j.ijrobp.2011.09.022. Epub 2011 Nov 16.

PMID:
22099048
7.

Intraoperative radiotherapy with localized radioprotection: diminished duodenal toxicity with intraluminal WR2721.

Halberg FE, LaRue SM, Rayner AA, Burnel WM, Powers BE, Chan AS, Schell MC, Gillette EL, Phillips TL.

Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1241-6.

PMID:
1657841
8.

Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.

Poorvu PD, Sadow CA, Townamchai K, Damato AL, Viswanathan AN.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1262-8. doi: 10.1016/j.ijrobp.2012.10.004. Epub 2012 Nov 20.

PMID:
23182395
9.

[Radiation injury to the duodenum (author's transl)].

Linhart P, Egger G.

Schweiz Rundsch Med Prax. 1982 Mar 2;71(9):383-7. German. No abstract available.

PMID:
6803234
10.

Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy.

Nakamura A, Shibuya K, Matsuo Y, Nakamura M, Shiinoki T, Mizowaki T, Hiraoka M.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):369-75. doi: 10.1016/j.ijrobp.2011.12.026. Epub 2012 Feb 28.

PMID:
22381898
11.

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1293-302.

PMID:
11955742
12.

5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.

Morganti AG, Valentini V, Macchia G, Mattiucci GC, Costamagna G, Deodato F, Smaniotto D, Luzi S, Balducci M, Barbi S, Perri V, Trodella L, Cellini N.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1454-60.

PMID:
15275732
13.

External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications.

Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K, Hiraoka M, Ohshio G, Imamura M, Takahashi M, Abe M.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):39-49.

PMID:
9300738
14.

Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.

Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF, Litwin S, Kowalyshyn MJ, Eisenberg BL.

Cancer. 1993 Oct 1;72(7):2124-33.

15.

Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients.

Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):111-8. doi: 10.1016/j.ijrobp.2010.01.065.

PMID:
20598450
16.

A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer.

Penberthy DR, Rich TA, Shelton CH 3rd, Adams R, Minasi JS, Jones RS.

Ann Oncol. 2001 May;12(5):681-4.

17.

Comparison of hyper-fractionated accelerated and standard fractionated radiotherapy with concomitant low-dose gemcitabine for unresectable pancreatic cancer.

Maemura K, Shinchi H, Noma H, Mataki Y, Kurahara H, Maeda S, Hiraki Y, Nakajo M, Natsugoe S, Takao S.

Anticancer Res. 2008 Jul-Aug;28(4C):2369-72.

20.

Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.

Miyamoto DT, Mamon HJ, Ryan DP, Willett CG, Ancukiewicz M, Kobayashi WK, Blaszkowsky L, Fernandez-del Castillo C, Hong TS.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1171-7. doi: 10.1016/j.ijrobp.2009.06.020. Epub 2009 Sep 30.

PMID:
19800182
Items per page

Supplemental Content

Write to the Help Desk